Neonatal Hypoglycemia September 2022
Neonatal Hypoglycemia September 2022
Neonatal Hypoglycemia September 2022
HYPOGLYCEMIA
SEPTEMBER 2022
SESSION OBJECTIVES
• Define neonatal hypoglycemia
• Describe the transition of the fetus to extrauterine life in terms of glucose regulation.
• Hypoglycaemia is when the blood glucose level below 2.5 mmol / l (45mg/dl)
(Essential Maternal and Newborn Clinical Care Guidelines for Uganda 2021)
Over view of fetal transition to extrauterine life in terms of
glucose regulation.
• endogenous source of glucose and other energy substrates necessary to sustain its metabolism the
result is the gradual rise of blood glucose levels over the next several hours to days is thus provided
• Any mechanism that disrupts this sequence of physiologic changes puts the infant at risk of more
severe or prolonged periods of low glucose. The risk for hypoglycemia is greatest in the first hours
after birth
Transition cont,
• The transition from intrauterine to extrauterine life involves many physiologic changes.
The fetus receives a constant supply of glucose from the mother across the placenta
• Healthy infants experience an expected drop in blood glucose concentrations
immediately following birth as a part of the normal physiologic transition to extrauterine
life.
• Abruptly clamping the umbilical cord at birth disrupts the infant's connection to the
placenta, upon which it relied to supply glucose and other metabolites necessary to meet
its energy needs in utero
• For most healthy infants, this transitional neonatal hypoglycemia is brief, transient and most often
asymptomatic
• It is important to differentiate this normal physiologic transitional response from disorders that result in
persistent or recurrent hypoglycemia, which if left untreated may lead to significant neurologic and
developmental sequelae
Risk factors for neonatal hypoglycaemia
• The most common causes of neonatal hypoglycaemia are deficient glycogen stores,
delayed feeding, and hyperinsulinemia.
• There are numerous risk factors associated with neonatal hypoglycemia
• They commonly include maternal conditions, such as
• obesity, diabetes, hypertension
• medications (eg, intravenous glucose, beta-blockers, and beta-agonist tocolytics)
substance use, pre-eclampsia, and gestational diabetes.
• cesarean delivery, discordant twins, polycythemia, inborn error of metabolism (IEM)
• genetic syndromes, endocrine abnormalities, respiratory distress, and other perinatal
complications (including a 5-min Apgar score
Risk factors cont,
• infants of diabetic mothers (IDM) and large for gestational age infants experience fetal
hyperinsulinism and increased peripheral glucose utilization, putting them at risk for
hypoglycemia in the immediate postnatal period
• The placenta supplies the fetus with a direct source of glucose via facilitated diffusion,
such that fetal glucose concentrations are proportional to maternal levels. Prolonged
elevations in maternal glucose concentrations result in fetal hyperglycemia and
pancreatic overstimulation to increase endogenous fetal insulin production.
• ]These elevated levels of fetal insulin persist after birth and, in the absence of a
continuous exogenous glucose source, result in increased glucose utilization and lower
blood glucose concentrations
• IDM have a decreased ability to mobilize glycogen stores after birth and experience a
relative adrenal insufficiency with decreased levels of catecholamines, further
contributing to the risk of low blood glucose levels
Risk factors cont..,
• Intrauterine growth restriction or small compared to gestational age infants .Late-
preterm infants (34 to 36.6 weeks gestational age)
• Preterm, intrauterine growth restricted and small for gestational age infants are at risk
for hypoglycemia because they are born with decreased glycogen stores, decreased
adipose tissue and experience increased metabolic demands because of their
relatively large brain size
• In very low birth weight (<1000 g) preterm infants, the enzymes involved in
gluconeogenesis are expressed at low levels; thus their ability to produce
endogenous glucose is poor, contributing to their risk of severe or prolonged low
glucose concentrations
Clinical presentation of neonatal hypoglycemia
• The clinical presentation of neonatal hypoglycemia is variable. An otherwise healthy infant may remain asymptomatic despite
extremely low blood glucose levels during the period of transitional hypoglycemia.
• Many infants remain asymptomatic.
Prolonged or severe hypoglycemia causes both adrenergic and neuroglycopenic signs.
• Adrenergic signs include diaphoresis include
-tachycardia,
-lethargy or weakness, and shakiness.
• Neuroglycopenic signs include
-seizure, coma,
-cyanotic episodes,
-apnea,
-bradycardia or respiratory distress,
- hypothermia.
-Listlessness, poor feeding, hypotonia, and tachypnea may occur
Diagnosis of Neonatal Hypoglycemia
• Bedside glucose check
• All signs are nonspecific and also occur in neonates who have asphyxia, sepsis or
hypocalcemia,
• Neonates with or without these signs require an immediate bedside blood glucose check
from a capillary sample. Abnormally low levels are confirmed by a venous sample.
-If the blood glucose is more than 105 mg/dl (6 mmol/l ) ( hyperglycaemia) on two consecutive
readings : - Change to a 5% glucose solution, if possible;
- Measure blood glucose again in three hours.
Differential diagnosis
• . The symptoms mentioned can be due to many other causes with or without associated
hypoglycemia.
• If symptoms persist after the glucose concentration is in the normal range, other etiologies
should be considered. Such as
Sepsis
-CNS disease oxic exposure
-Metabolic abnormalities
-Hypocalcemia
-Hyponatremia or hypernatremia
-Hypomagnesemia
-Pyridoxine deficiency
-Adrenal insufficiency
Management
The goals of managing neonatal hypoglycemia are:
• To correct blood glucose levels in symptomatic neonates
• To prevent symptomatic hypoglycemia in at-risk patients
• To avoid unnecessary treatment of infants with physiologic low blood glucose
during the transition to extrauterine life, which will self-resolve without
intervention
• To identify newborns with a serious underlying hypoglycemic disorder
• Prevent long-term neurologic sequelae of neonatal hypoglycemia
IV therapy Medical Management
• a. Indications i. Inability to tolerate oral feeding
• ii. Symptoms
• iii. Oral feedings do not maintain normal glucose levels
• iv. Glucose levels less than 25 mg/dL
b. Urgent treatment
i. 200 mg/kg of glucose over 1 minute, to be followed by continuing therapy discussed
subsequently
ii. This initial treatment is equivalent to 2 mL/kg of dextrose 10% in water (10% D/W) infused
intravenously
c. Continuing therapy i. Infusion of glucose at a rate of 6 to 8 mg of glucose/kg per minute ii.
10% D/W at a rate of 86.4 mL/kg per day or 3.6 mL/kg per hour gives 6 mg/kg per minute of
Nursing Management
• Nurses providing ongoing care at the bedside are often the first to identify an infant at risk
for developing hypoglycemia. Prophylactic care for any infant assessed to be at risk for
hypoglycemia includes (Narvey & Marks, 2019):
• Early enteral feeding,
• Difficulties with infant latching, poor feeding, and low volumes of breast-milk may interfere
with the successful establishment of early breastfeeding in the first hours of life.should be
addressed
• Ensure that the mother can properly express breast milk Insert a gastric tube if one is not
already in place.
• Confirm that the tube is properly positioned before each feeding.
• Encourage the mother to hold the baby and participate in feedings.
• Determine the required volume of milk for the feed according to the baby’s age
• (Remove the plunger of a high-level disinfected or sterile syringe (of a size large
enough to hold the required volume of milk) and connect the barrel of the syringe to the
end of the gastric tube:
• If a high-level disinfected or sterile syringe is not available, use a clean (washed, boiled or rinsed
with boiled water, and air-dried) syringe;
• If a suitable syringe is not available, use any other suitable, clean funnel that connects snugly to the
gastric tube.
F eeding expressed breast milk by gastric
tube cont,
• Pour the required volume of milk for the feed into the syringe with the
“tip” of the syringe pointed downward.
• Have the mother hold the syringe 5 to 10 cm above the baby or suspend
the tube above the baby and allow the milk to run down the tube by
gravity. Do not force milk through the tube using the plunger of the
syringe.
Education needs
Education for family members regarding hypoglycaemia is an important aspect of the neonate’s
holistic care.
• Education may include:
• Risk factors and causes of neonatal hypoglycaemia
• What care is given to sick neonates unable to breast feed? Emphasis on IPC?
• Explain what you appreciated most or what would do differently in the
prevention and management of neonatal hypoglycaemia
References
Ministry of Health Uganda , (2021) Essential Maternal and Newborn
Clinical Care Guidelines for Uganda
Manual of neonatal care / editors, John P. Cloherty ... [et al.]. — 7th ed.